These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 27745736)

  • 1. Evaluation of apramycin activity against carbapenem-resistant and -susceptible strains of Enterobacteriaceae.
    Smith KP; Kirby JE
    Diagn Microbiol Infect Dis; 2016 Dec; 86(4):439-441. PubMed ID: 27745736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of apramycin against multidrug-, carbapenem- and aminoglycoside-resistant Enterobacteriaceae and Acinetobacter baumannii.
    Juhas M; Widlake E; Teo J; Huseby DL; Tyrrell JM; Polikanov YS; Ercan O; Petersson A; Cao S; Aboklaish AF; Rominski A; Crich D; Böttger EC; Walsh TR; Hughes D; Hobbie SN
    J Antimicrob Chemother; 2019 Apr; 74(4):944-952. PubMed ID: 30629184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of apramycin resistant Enterobacteriaceae in hospital isolates.
    Chaslus-Dancla E; Glupcznski Y; Gerbaud G; Lagorce M; Lafont JP; Courvalin P
    FEMS Microbiol Lett; 1989 Oct; 52(3):261-5. PubMed ID: 2612876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of aminoglycosides, including ACHN-490, against carbapenem-resistant Enterobacteriaceae isolates.
    Livermore DM; Mushtaq S; Warner M; Zhang JC; Maharjan S; Doumith M; Woodford N
    J Antimicrob Chemother; 2011 Jan; 66(1):48-53. PubMed ID: 21078604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tigecycline activity tested against carbapenem-resistant Enterobacteriaceae from 18 European nations: results from the SENTRY surveillance program (2010-2013).
    Sader HS; Castanheira M; Flamm RK; Mendes RE; Farrell DJ; Jones RN
    Diagn Microbiol Infect Dis; 2015 Oct; 83(2):183-6. PubMed ID: 26164275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emergence of carbapenem-resistant Enterobacteriaceae isolates in the Moroccan community.
    Barguigua A; El Otmani F; Talmi M; Zerouali K; Timinouni M
    Diagn Microbiol Infect Dis; 2012 Jul; 73(3):290-1. PubMed ID: 22521054
    [No Abstract]   [Full Text] [Related]  

  • 7. Apramycin efficacy against carbapenem- and aminoglycoside-resistant Escherichia coli and Klebsiella pneumoniae in murine bloodstream infection models.
    Frimodt-Møller N; Hansen JU; Plattner M; Huseby DL; Radmer Almind S; Haldimann K; Gysin M; Petersson A; Ercan O; Ganz L; Hughes D; Vingsbo Lundberg C; Hobbie SN
    Int J Antimicrob Agents; 2024 Jul; 64(1):107181. PubMed ID: 38653351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of apramycin activity against methicillin-resistant, methicillin-sensitive, and vancomycin-intermediate Staphylococcus aureus clinical isolates.
    Truelson KA; Brennan-Krohn T; Smith KP; Kirby JE
    Diagn Microbiol Infect Dis; 2018 Oct; 92(2):168-171. PubMed ID: 29934071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline.
    Livermore DM; Warner M; Mushtaq S; Doumith M; Zhang J; Woodford N
    Int J Antimicrob Agents; 2011 May; 37(5):415-9. PubMed ID: 21429716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging trends in epidemiology and management of infections caused by carbapenem-resistant Enterobacteriaceae.
    Martirosov DM; Lodise TP
    Diagn Microbiol Infect Dis; 2016 Jun; 85(2):266-75. PubMed ID: 27033631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of apramycin against spectinomycin-resistant and -susceptible strains of Neisseria gonorrhoeae.
    Riedel S; Vijayakumar D; Berg G; Kang AD; Smith KP; Kirby JE
    J Antimicrob Chemother; 2019 May; 74(5):1311-1316. PubMed ID: 30689929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of Apramycin against Multidrug-Resistant Acinetobacter baumannii in the Murine Neutropenic Thigh Model.
    Kang AD; Smith KP; Berg AH; Truelson KA; Eliopoulos GM; McCoy C; Kirby JE
    Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29339396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of BAL30072 alone or combined with β-lactamase inhibitors or with meropenem against carbapenem-resistant Enterobacteriaceae and non-fermenters.
    Mushtaq S; Woodford N; Hope R; Adkin R; Livermore DM
    J Antimicrob Chemother; 2013 Jul; 68(7):1601-8. PubMed ID: 23449829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-surgical mediastinitis due to carbapenem-resistant Enterobacteriaceae: Clinical, epidemiological and survival characteristics.
    Abboud CS; Monteiro J; Stryjewski ME; Zandonadi EC; Barbosa V; Dantas D; Sousa EE; Fonseca MJ; Jacobs DM; Pignatari AC; Kiffer C; Rao GG
    Int J Antimicrob Agents; 2016 May; 47(5):386-90. PubMed ID: 27155944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fosfomycin activity versus carbapenem-resistant Enterobacteriaceae and vancomycin-resistant Enterococcus, Detroit, 2008-10.
    Pogue JM; Marchaim D; Abreu-Lanfranco O; Sunkara B; Mynatt RP; Zhao JJ; Bheemreddy S; Hayakawa K; Martin ET; Dhar S; Kaye KS; Lephart PR
    J Antibiot (Tokyo); 2013 Oct; 66(10):625-7. PubMed ID: 23715037
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevalence and mechanisms of resistance to carbapenems in Enterobacteriaceae isolates from 24 hospitals in Belgium.
    Huang TD; Berhin C; Bogaerts P; Glupczynski Y;
    J Antimicrob Chemother; 2013 Aug; 68(8):1832-7. PubMed ID: 23557926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apramycin susceptibility of multidrug-resistant Gram-negative blood culture isolates in five countries in Southeast Asia.
    Gysin M; Hon PY; Tan P; Sengduangphachanh A; Simmalavong M; Hinfonthong P; Kaewphanderm N; Pham TD; Nguyen TH; Haldimann K; Becker K; van Doorn HR; Hopkins J; Simpson AJH; Ashley EA; Kesteman T; Tran HH; Vasoo S; Ling CL; Roberts T; Turner P; Hobbie SN
    Int J Antimicrob Agents; 2022 Oct; 60(4):106659. PubMed ID: 35988665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection and characterization of aparmycin-resistant Escherichia coli from humans in Korea.
    Lim SK; Nam HM; Kim A; Jang GC; Lee HS; Jung SC
    Microb Drug Resist; 2011 Dec; 17(4):563-6. PubMed ID: 21905874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emergence of carbapenem-resistant Enterobacteriaceae in a UK paediatric hospital.
    Drew RJ; Turton JF; Hill RL; Livermore DM; Woodford N; Paulus S; Cunliffe NA
    J Hosp Infect; 2013 Aug; 84(4):300-4. PubMed ID: 23831281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful containment of carbapenem-resistant Enterobacteriaceae by strict contact precautions without active surveillance.
    Kim NH; Han WD; Song KH; Seo HK; Shin MJ; Kim TS; Park KU; Ahn S; Yoo JS; Kim ES; Kim HB
    Am J Infect Control; 2014 Dec; 42(12):1270-3. PubMed ID: 25465255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.